您好，欢迎来到国际肝病网！
其他专题：
APASL
|
APASL2014
|
APASL2013
|
APASL2012
|
APASL2011
|
APASL2010
|
APASL2009
|
国际肝病
网站首页
专题首页
会议动态
摘要赏析
专家访谈
现场快报
主题演讲
壁报展示
精彩幻灯
图片新闻
视频播报
精彩幻灯
专题首页
» 精彩幻灯
Treatment Goals: Can Chronic Hepatitis B be Cured? The View of the Virologist
Treatment Goals: Can Chronic Hepatitis B be Cured? In the view of hepatologist
Current Optimal HBV Treatment in HBeAg-positive patients
Update in natural history of HBV infection; Do we really understand it?
There is still a role for interferon in the treatment of HBeAg negative CHB PRO
There is still a role for interferon in the treatment of HBeAg negative CHB CON
HBV in immunosuppression, chemotherapy & transplant recipients
Severe Acute Hepatitis B Treat
Severe Acute Hepatitis B Not To Treat
Chronic Hepatitis B - Predictive factors for disease progression
Predictability in Chronic HBV – Treatment Response
Management of CHB with Normal ALT
Update APASL consensus on management of chronic hepatitis B
Optimize HCV treatment to maximize cost- effectiveness
Emerging therapy for chronic hepatitis C
Treatment of Acute HCV Infection
Management of Chronic hepatitis C in Special Populations Normal ALT, HIV Co-infection, Renal Failure
Symposium on non-alcoholic fatty liver disease
NAFLD in Asia Pacific Perspective
Update and Novel Therapies in Non-Alcoholic Fatty Liver Disease
首页
1
2
下一页
尾页
专题标签
学术领域
扫描二维码，用手机看今日话题
